Safety is paramount in vaccine scientific trials and momentary suspensions usually are not uncommon to judge any unexplained sickness in a participant, the World Health Organization (WHO) mentioned on Thursday concerning the pause in an AstraZeneca COVID-19 trial.
AstraZeneca has suspended world trials of its experimental coronavirus vaccine after an unexplained sickness in a participant, knocking the British drugmaker’s shares on Wednesday as prospects for an early rollout dimmed.
“We are pleased to see vaccine developers assuring the scientific integrity of the trials and abiding by the standard guidelines and rules for the development of vaccines,” the WHO mentioned by electronic mail in response to a Reuters question.
The WHO beneficial “strict adherence to established testing protocols in all vaccine trials to ensure the safety of volunteers and the eventual safety and efficacy of vaccines”, it added.
(This story has not been edited by NDTV employees and is auto-generated from a syndicated feed.)